The 5th International conference on Malaria Vaccines for the World (MVW) was held on May 8-10 at the University of Oxford, UK. The current status of new technologies, vaccine candidates, clinical trials and the RTS/s implementation studies were discussed during three intensive days, and here you can read coverage of each session from the MESA Correspondents.
- Session 1: Opening plenary session
- Session 2: PfSPZ-based vaccines: Phase 3 to licensure to deployment to use in elimination campaigns to next generations
- Session 3: PfSPZ-based vaccines: Innovations and immunology to improve efficacy and reduce cost of goods
- Session 4: Recent advances - Blood-stage vaccines
- Session 5: Recent advances - Sporozoite and liver-stage vaccines
- Session 6: Special PATH/WHO session
- Session 7: Cellular and antibody vaccine immunology
- Session 8: Structure-guided vaccine design and recent advances in transmission-blocking vaccines
- Session 9: Latest advances in vaccines and CHMI for P. vivax
- Session 10: Novel approaches to antigen discovery, vaccine delivery and adjuvants
Tags: